Engineered nanoparticles as precise drug delivery systems

被引:262
作者
Yih, TC [1 ]
Al-Fandi, M [1 ]
机构
[1] Univ Texas, Dept Mech Engn & Biomech, San Antonio, TX 78249 USA
关键词
nanoparticles; architecture; material; nanotechnology; drug delivery; therapeutic agent; therapeutic application;
D O I
10.1002/jcb.20796
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
With the remarkable development of nanotechnology in recent years, new drug delivery approaches based on the state-of-the-art nanotechnology have been receiving significant attention. Nanoparticles, all evolvement of nanotechnology, are increasingly considered as a potential candidate to carry therapeutic agents safely into a targeted compartment in an organ, particular tissue or cell. These particles are colloidal structures with a diameter smaller than 1,000 nm, and therefore can penetrate through diminutive capillaries into the cell's internal machinery. This innovative delivery technique might be a promising technology to meet the current challenges in drug delivery. When loaded with a gene or drug agent, nanoparticles can become nanopills, which can effectively treat problematical diseases such as cancer. This article summarizes different types of nanoparticles drug delivery systems under investigation and their prospective therapeutic applications. Also, this article presents a closer look at the advances, current challenges, and future direction of nanoparticles drug delivery systems.
引用
收藏
页码:1184 / 1190
页数:7
相关论文
共 51 条
[1]  
Al Khouri F, 1986, INT J PHARMACEUT, V28, P125
[2]   Dendrimers in drug research [J].
Boas, U ;
Heegaard, PMH .
CHEMICAL SOCIETY REVIEWS, 2004, 33 (01) :43-63
[3]   Nanoparticles in cancer therapy and diagnosis [J].
Brigger, I ;
Dubernet, C ;
Couvreur, P .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (05) :631-651
[4]   Interactions between dendrimer biocides and bacterial membranes [J].
Chen, CZS ;
Cooper, SL .
BIOMATERIALS, 2002, 23 (16) :3359-3368
[5]   Self-assembled carbohydrate-stabilized ceramic nanoparticles for the parenteral delivery of insulin [J].
Cherian, AK ;
Rana, AC ;
Jain, SK .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2000, 26 (04) :459-463
[6]   Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles [J].
Cohen, H ;
Levy, RJ ;
Gao, J ;
Fishbein, I ;
Kousaev, V ;
Sosnowski, S ;
Slomkowski, S ;
Golomb, G .
GENE THERAPY, 2000, 7 (22) :1896-1905
[7]   Immunostimulation mechanism of LPD nanoparticle as a vaccine carrier [J].
Cui, Zhengrong ;
Han, Su-Ji ;
Vangasseri, Dileep Padinjarae ;
Huang, Leaf .
MOLECULAR PHARMACEUTICS, 2005, 2 (01) :22-28
[8]  
Davis SS, 1998, INT J PHARM, V176, P1
[9]  
DEY S, 2005, P 6 AN CAMBR HLTH I
[10]   Targeting of stealth liposomes to erbB-2 (Her/2) receptor: In vitro and in vivo studies [J].
Goren, D ;
Horowitz, AT ;
Zalipsky, S ;
Woodle, MC ;
Yarden, Y ;
Gabizon, A .
BRITISH JOURNAL OF CANCER, 1996, 74 (11) :1749-1756